Barclays boss reveals cancer diagnosis but will continue to manage bank

CS Venkatakrishnan told staff in a letter that he will receive treatment at a cancer centre in New York which is likely to last 12 to 16 weeks.

Anna Wise
Monday 28 November 2022 10:52
Banking giant Barclays has revealed its chief executive CS Venkatakrishnan is undergoing treatment after being diagnosed with non-Hodgkin lymphoma (Yui Mok/PA)
Banking giant Barclays has revealed its chief executive CS Venkatakrishnan is undergoing treatment after being diagnosed with non-Hodgkin lymphoma (Yui Mok/PA)

Banking giant Barclays has revealed its chief executive CS Venkatakrishnan is undergoing treatment after being diagnosed with non-Hodgkin lymphoma.

Mr Venkatakrishnan, known as Venkat, told staff in a letter that he will receive treatment at a cancer centre in New York which is likely to last 12 to 16 weeks.

He said the lender will run normally during this time and he will still be “actively engaged in managing it”.

He wrote in the letter: “I am writing to inform you that I have been diagnosed with non-Hodgkin lymphoma. The good news is that the matter has been detected early, with scans and biopsies confirming it to be very localised.

I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders

CS Venkatakrishnan

“The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen.”

The CEO said he will have to work from home for some periods and will not be able to travel.

Non-Hodgkin lymphoma is a type of cancer that develops in the lymphatic system, and most cases are considered very treatable, according to the NHS.

Mr Venkatakrishnan said Barclays’ senior management team will be well-equipped to help lead the business while he undergoes treatment.

He added: “We have a highly capable and seasoned executive committee, supported by a talented senior management team.

“I am very confident that we will continue, with your help, to serve our customers and clients well, and produce strong operating performance for our shareholders.

“I am deeply appreciative, and very proud, of your support and extraordinary efforts in these volatile times.”

Mr Venkatakrishnan took on the chief executive role a year ago, having previously been head of global markets.

He succeeded Jes Staley, who stepped down suddenly after an investigation by the Financial Conduct Authority (FCA) into his links to the late convicted sex offender Jeffrey Epstein.

Mr Staley also ran into trouble with the FCA a year after becoming Barclays’ boss, when he was investigated over an attempt to identify a whistleblower.

His pay was docked as a result of his conduct which contravened the lender’s whistleblowing programme.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in